Document is current
Any future updates will be listed below
-
Authors
García-Peñas, Juan José https://orcid.org/0000-0002-6292-3287
Calvo-Medina, Rocío https://orcid.org/0000-0003-3322-4265
García-Ron, Adrián
Gil-Nagel, Antonio https://orcid.org/0000-0003-4515-0793
Villanueva, Vicente https://orcid.org/0000-0003-2080-8042
Sánchez-Carpintero, Rocío https://orcid.org/0000-0002-5058-0686
-
Funding
Funding for this research was provided by:
Biocodex Microbiota Foundation
- License Information
-
More Information
Article History
Received: 10 September 2024
Accepted: 18 October 2024
First Online: 4 November 2024
Declarations
:
: Juan José García-Peñas has participated in advisory boards and symposia organized by Bial, Biocodex, Eisai Inc, Jazz Pharmaceuticals, Nutricia, Sanofi, and UCB; and has received congress sponsorship from Bial, Eisai Inc, Jazz Pharmaceuticals, Nutricia, Sanofi, and UCB. Rocío Calvo-Medina has participated in advisory boards and symposia organized by Biocodex. Adrián García-Ron has participated in advisory boards and symposia organized by Biocodex, Eisai Inc, Jazz Pharmaceuticals, and UCB. Antonio Gil-Nagel has participated in advisory boards and symposia organized by Angelini Pharma, Bial, Biocodex, Eisai, Jazz Pharmaceuticals, Rapport Therapeutics, Stoke, and UCB. Vicente Villanueva has participated in advisory boards and symposium organized by Angelini Pharma, Bial, Biocodex, Eisai Inc, Jazz Pharmaceuticals, Novartis, Paladin, Takeda, UCB, and Xenon. Rocío Sánchez-Carpintero has participated in advisory boards and symposium organized by Biocodex, Jazz Pharmaceuticals, and UCB.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
